Skip to main content

Benefit of angiographic spontaneous reperfusion in STEMI: does it extend to diabetic patients?

Publication ,  Journal Article
Bainey, KR; Fu, Y; Granger, CB; Hamm, CW; Holmes, DR; O'Neill, WW; Seabra-Gomes, R; Pfisterer, ME; Van de Werf, F; Armstrong, PW ...
Published in: Heart
August 2009

BACKGROUND: Spontaneous reperfusion (SR) in ST elevation myocardial infarction (STEMI) improves clinical outcome, yet its incidence and impact among diabetic patients is unclear. OBJECTIVE: To carry out a systematic analysis of SR in the diabetic cohort of a large primary percutaneous coronary intervention (PCI)-treated population with STEMI. METHODS AND RESULTS: 4944 patients (15.5% diabetic) undergoing primary PCI in the APEX AMI study were evaluated. SR defined as pre-PCI Thrombolysis in Myocardial Infarction (TIMI) 3 flow occurred in 11.5% of patients; it was more common in non-diabetic (11.9%) than in diabetic patients (9.2%) (p = 0.028). Patients with SR versus no SR had improved post-PCI TIMI 3 flow: in non-diabetic patients (99.8% vs 90.3%, p<0.001) and in diabetic patients (98.6% vs 84.9%, p<0.001). Non-diabetic patients with SR showed a significant improvement in 90-day death/shock/congestive heart failure (CHF) compared with those without SR: 4.4% versus 8.9% (p = 0.001), respectively. The composite outcome in diabetic patients with versus without SR was 10.0% versus 14.9% (p = 0.270), respectively. When outcomes were examined according to tertiles of baseline blood glucose, both non-diabetic and diabetic patients with normoglycaemia showed higher SR rates (15.5%, 10.3%, 7.3% for non-diabetic patients, p<0.001; 17.4%, 7.2%, 9.1% for diabetic patients, p = 0.132), greater ST resolution (55.4%, 52.6%, 49.7% for non-diabetic patients, p = 0.030; 50%, 46.4%, 39.1% for diabetic patients, p = 0.179), and improved 90-day death/shock/CHF (5.2%, 8.3%, 14% for non-diabetic patients p<0.001; 8.7%, 4.2%, 15.8% for diabetic patients, p = 0.006). CONCLUSIONS: These data indicate that SR is less common in diabetic patients with STEMI. Diabetic patients without SR have worse post-PCI epicardial patency, which contributes to adverse outcomes. Diabetic patients with normal baseline blood glucose and SR have enhanced epicardial flow after PCI and improved prognosis.

Duke Scholars

Published In

Heart

DOI

EISSN

1468-201X

Publication Date

August 2009

Volume

95

Issue

16

Start / End Page

1331 / 1336

Location

England

Related Subject Headings

  • Vasodilator Agents
  • Treatment Outcome
  • Single-Chain Antibodies
  • Remission, Spontaneous
  • Myocardial Reperfusion
  • Myocardial Infarction
  • Middle Aged
  • Male
  • Humans
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Bainey, K. R., Fu, Y., Granger, C. B., Hamm, C. W., Holmes, D. R., O’Neill, W. W., … APEX AMI Investigators. (2009). Benefit of angiographic spontaneous reperfusion in STEMI: does it extend to diabetic patients? Heart, 95(16), 1331–1336. https://doi.org/10.1136/hrt.2008.160390
Bainey, K. R., Y. Fu, C. B. Granger, C. W. Hamm, D. R. Holmes, W. W. O’Neill, R. Seabra-Gomes, et al. “Benefit of angiographic spontaneous reperfusion in STEMI: does it extend to diabetic patients?Heart 95, no. 16 (August 2009): 1331–36. https://doi.org/10.1136/hrt.2008.160390.
Bainey KR, Fu Y, Granger CB, Hamm CW, Holmes DR, O’Neill WW, et al. Benefit of angiographic spontaneous reperfusion in STEMI: does it extend to diabetic patients? Heart. 2009 Aug;95(16):1331–6.
Bainey, K. R., et al. “Benefit of angiographic spontaneous reperfusion in STEMI: does it extend to diabetic patients?Heart, vol. 95, no. 16, Aug. 2009, pp. 1331–36. Pubmed, doi:10.1136/hrt.2008.160390.
Bainey KR, Fu Y, Granger CB, Hamm CW, Holmes DR, O’Neill WW, Seabra-Gomes R, Pfisterer ME, Van de Werf F, Armstrong PW, APEX AMI Investigators. Benefit of angiographic spontaneous reperfusion in STEMI: does it extend to diabetic patients? Heart. 2009 Aug;95(16):1331–1336.

Published In

Heart

DOI

EISSN

1468-201X

Publication Date

August 2009

Volume

95

Issue

16

Start / End Page

1331 / 1336

Location

England

Related Subject Headings

  • Vasodilator Agents
  • Treatment Outcome
  • Single-Chain Antibodies
  • Remission, Spontaneous
  • Myocardial Reperfusion
  • Myocardial Infarction
  • Middle Aged
  • Male
  • Humans
  • Female